Cardiac ailments cause 17.9 million deaths every year that is around 31% of the mortality rate globally. Variety of regimens are available to treat heart diseases. FDA has approved Valsartan Generic product for necessitating cardiac cases. Valsartan is one of those drugs which is used in the treatment of high blood pressure, heart failure, etc.
Recently in some batches of Valsartan, some impurities and chemicals such as NDEM or NDMA, N-nitroso dimethylamine were found in trace amount. Due to this, several pharma companies involved in the production of the drug had pulled those batches from the market. As a result, shortage of Valsartan was experienced in the market. Examining the need and shortage of Valsartan, the FDA has finally approved the Valsartan generic drug Source: NBC News
